

Sotyktu costs over $2,000/month without insurance. Learn how to save with coupons, discount cards, and patient assistance programs in 2026.
If you've looked into the cost of Sotyktu (Deucravacitinib), you already know it's not cheap. Without insurance, Sotyktu costs approximately $2,000 to $2,400 per month — that's roughly $72,000 to $80,000 per year for a once-daily pill.
The good news? Most patients don't pay anywhere near the full price. Between manufacturer savings programs, coupon cards, patient assistance programs, and insurance coverage, there are several ways to bring your out-of-pocket cost down significantly — in many cases to $0 per month.
In this guide, we'll walk through every major option for saving money on Sotyktu in 2026.
Let's start with the numbers:
These prices reflect the wholesale acquisition cost and typical retail cash prices. The actual price you see may vary by pharmacy. Specialty pharmacies may charge slightly different amounts than retail locations.
Several coupon and discount card platforms can help reduce the cost of Sotyktu, especially if you're paying cash or have a high-deductible plan:
This is the most valuable savings tool for commercially insured patients. Key details:
SingleCare offers free discount cards that may provide savings on Sotyktu at participating pharmacies. Pricing varies by location, but it's worth checking — especially if you don't qualify for the manufacturer card.
GoodRx aggregates pricing from multiple sources and may show discounted prices for Sotyktu at pharmacies near you. Note that for specialty medications, GoodRx prices may not reflect the deep discounts seen with generic drugs.
Additional platforms to check include:
While the savings on a specialty brand-name drug like Sotyktu may be modest compared to generics, it's always worth comparing prices across platforms.
If you're uninsured, underinsured, or facing financial hardship, patient assistance programs can provide Sotyktu at no cost. These programs are income-based and typically require an application.
This is the primary assistance program for Sotyktu. Key details:
NeedyMeds is a nonprofit that maintains a database of patient assistance programs. Search for Deucravacitinib or Sotyktu to find current programs, eligibility requirements, and application forms.
RxAssist is another comprehensive database of patient assistance programs. It's a useful resource for finding both manufacturer and nonprofit programs.
RxHope helps connect patients with assistance programs and can guide you through the application process.
If you have insurance, make sure Sotyktu is on your plan's formulary. Key steps:
Prices can vary between specialty pharmacies. If you're paying out of pocket, call multiple specialty pharmacies to compare pricing. Some may offer competitive rates or payment plans.
Some insurance plans use copay accumulator programs that prevent manufacturer savings cards from counting toward your deductible. If your plan has this, ask your benefits department or pharmacist about options — some patients switch to plans without accumulators during open enrollment.
If your out-of-pocket medical expenses exceed 7.5% of your adjusted gross income, you may be able to deduct them on your federal tax return. Keep records of all Sotyktu-related expenses.
Sotyktu's list price is undeniably high, but the actual cost to patients varies enormously depending on insurance coverage and savings programs. The BMS Savings Card alone can bring the cost to $0 for commercially insured patients, and the BMS Patient Assistance Foundation can provide the drug for free to eligible uninsured patients.
Start by asking your dermatologist about the BMS Savings Card. If you're uninsured, apply for patient assistance. And always compare prices across platforms like SingleCare and GoodRx.
Need help finding a pharmacy that has Sotyktu in stock? Use Medfinder to check real-time availability near you. And for a full overview of the medication, read What is Sotyktu?
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.